These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24115079)

  • 1. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice.
    Harley IT; Stankiewicz TE; Giles DA; Softic S; Flick LM; Cappelletti M; Sheridan R; Xanthakos SA; Steinbrecher KA; Sartor RB; Kohli R; Karp CL; Divanovic S
    Hepatology; 2014 May; 59(5):1830-9. PubMed ID: 24115079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.
    Giles DA; Moreno-Fernandez ME; Stankiewicz TE; Cappelletti M; Huppert SS; Iwakura Y; Dong C; Shanmukhappa SK; Divanovic S
    PLoS One; 2016; 11(2):e0149783. PubMed ID: 26895034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression.
    Giles DA; Moreno-Fernandez ME; Divanovic S
    Curr Drug Targets; 2015; 16(12):1315-23. PubMed ID: 26028039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
    Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
    World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation.
    Shen T; Chen X; Li Y; Tang X; Jiang X; Yu C; Zheng Y; Guo H; Ling W
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1510-1518. PubMed ID: 28153707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.
    Lambertucci F; Arboatti A; Sedlmeier MG; Motiño O; Alvarez ML; Ceballos MP; Villar SR; Roggero E; Monti JA; Pisani G; Quiroga AD; Martín-Sanz P; Carnovale CE; Francés DE; Ronco MT
    J Nutr Biochem; 2018 Aug; 58():17-27. PubMed ID: 29860102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.
    Jeftic I; Jovicic N; Pantic J; Arsenijevic N; Lukic ML; Pejnovic N
    Mol Med; 2015 May; 21(1):453-65. PubMed ID: 26018806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
    Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice.
    Xu R; Tao A; Zhang S; Zhang M
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):726-33. PubMed ID: 23786840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet-induced obesity associated with steatosis, oxidative stress, and inflammation in liver.
    Peng Y; Rideout D; Rakita S; Lee J; Murr M
    Surg Obes Relat Dis; 2012; 8(1):73-81. PubMed ID: 21978752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.
    Miller AM; Wang H; Bertola A; Park O; Horiguchi N; Ki SH; Yin S; Lafdil F; Gao B
    Hepatology; 2011 Sep; 54(3):846-56. PubMed ID: 21725996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
    Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M
    J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.
    Handa P; Maliken BD; Nelson JE; Morgan-Stevenson V; Messner DJ; Dhillon BK; Klintworth HM; Beauchamp M; Yeh MM; Elfers CT; Roth CL; Kowdley KV
    Hepatology; 2014 Jul; 60(1):133-45. PubMed ID: 24464605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
    Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
    Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.
    Giles DA; Moreno-Fernandez ME; Stankiewicz TE; Graspeuntner S; Cappelletti M; Wu D; Mukherjee R; Chan CC; Lawson MJ; Klarquist J; Sünderhauf A; Softic S; Kahn CR; Stemmer K; Iwakura Y; Aronow BJ; Karns R; Steinbrecher KA; Karp CL; Sheridan R; Shanmukhappa SK; Reynaud D; Haslam DB; Sina C; Rupp J; Hogan SP; Divanovic S
    Nat Med; 2017 Jul; 23(7):829-838. PubMed ID: 28604704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
    Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.
    Caputo M; Kurhe Y; Kumari S; Cansby E; Amrutkar M; Scandalis E; Booten SL; Ståhlman M; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    FASEB J; 2021 May; 35(5):e21567. PubMed ID: 33891332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.